Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Modlin

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Clinical Pediatrics|May 4, 2007
Congenital rubella syndrome in a child born to Liberian refugees: clinical and public health perspectivesRachel N Plotinsky, Elizabeth A Talbot, Joan E Kellenberg, et al.
Emerging Infectious Diseases|May 15, 2019
Facility-Associated Release of Polioviruses into Communities-Risks for the Posteradication EraAnanda S Bandyopadhyay, Harpal Singh, Jacqueline Fournier-Caruana, et al.
Vaccine|November 19, 2017
Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedulesAnanda S Bandyopadhyay, Edwin J Asturias, Miguel O'Ryan, et al.
Archives of Pathology & Laboratory Medicine|June 3, 2011
A fatal central nervous system enterovirus 68 infectionJustin D Kreuter, Arti Barnes, James E McCarthy, et al.
Mucosal Immunology|July 9, 2021
Mucosal immunity to poliovirusRuth I Connor, Elizabeth B Brickley, Wendy F Wieland-Alter, et al.
The Journal of Infectious Diseases|October 16, 2014
Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradicationMark A McKinlay, Marc S Collett, Jeffrey R Hincks, et al.
Vaccine|March 4, 2025
Binding and neutralising antibodies to respiratory syncytial virus and influenza A virus in serum and bronchoalveolar lavage fluid of healthy adults in the United States: A cross-sectional studyAmber I Raja, Ruth I Connor, Alix Ashare, et al.
The Lancet. Infectious Diseases|July 12, 2017
Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling studyMami Taniuchi, Michael Famulare, Khalequ Zaman, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 19, 2012
Expert review on poliovirus immunity and transmissionRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2025
Intestinal mucosal immune responses to novel oral poliovirus vaccine type 2 in healthy newbornsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Clinical Pediatrics|May 4, 2007
Congenital rubella syndrome in a child born to Liberian refugees: clinical and public health perspectivesRachel N Plotinsky, Elizabeth A Talbot, Joan E Kellenberg, et al.
Emerging Infectious Diseases|May 15, 2019
Facility-Associated Release of Polioviruses into Communities-Risks for the Posteradication EraAnanda S Bandyopadhyay, Harpal Singh, Jacqueline Fournier-Caruana, et al.
Vaccine|November 19, 2017
Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedulesAnanda S Bandyopadhyay, Edwin J Asturias, Miguel O'Ryan, et al.
Archives of Pathology & Laboratory Medicine|June 3, 2011
A fatal central nervous system enterovirus 68 infectionJustin D Kreuter, Arti Barnes, James E McCarthy, et al.
Mucosal Immunology|July 9, 2021
Mucosal immunity to poliovirusRuth I Connor, Elizabeth B Brickley, Wendy F Wieland-Alter, et al.
The Journal of Infectious Diseases|October 16, 2014
Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradicationMark A McKinlay, Marc S Collett, Jeffrey R Hincks, et al.
Vaccine|March 4, 2025
Binding and neutralising antibodies to respiratory syncytial virus and influenza A virus in serum and bronchoalveolar lavage fluid of healthy adults in the United States: A cross-sectional studyAmber I Raja, Ruth I Connor, Alix Ashare, et al.
The Lancet. Infectious Diseases|July 12, 2017
Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling studyMami Taniuchi, Michael Famulare, Khalequ Zaman, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 19, 2012
Expert review on poliovirus immunity and transmissionRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 4, 2025
Intestinal mucosal immune responses to novel oral poliovirus vaccine type 2 in healthy newbornsAudrey Godin, Elizabeth B Brickley, Ruth I Connor, et al.
Pageof 4